---
title: "Rundu Pharma: Valsartan Amlodipine Tablets (I) Obtains Drug Registration Certificate"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/259276532.md"
description: "According to the Zhitong Finance APP, Rundu Pharma announced that the company recently received the \"Drug Registration Certificate\" issued by the National Medical Products Administration, involving the drug: Valsartan and Amlodipine Tablets (I). This product is suitable for the treatment of primary hypertension. It is used for patients whose blood pressure cannot be adequately controlled with monotherapy"
datetime: "2025-09-29T07:56:03.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/259276532.md)
  - [en](https://longbridge.com/en/news/259276532.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/259276532.md)
generator: "portal-rs"
---

# Rundu Pharma: Valsartan Amlodipine Tablets (I) Obtains Drug Registration Certificate

According to the Zhitong Finance APP, Rundu Pharma (002923.SZ) announced that it recently received the "Drug Registration Certificate" issued by the National Medical Products Administration, involving the drug: Valsartan and Amlodipine Tablets (I). This product is suitable for the treatment of primary hypertension. It is used for patients whose blood pressure cannot be adequately controlled with monotherapy

### Related Stocks

- [002923.CN](https://longbridge.com/en/quote/002923.CN.md)

## Related News & Research

- [Trump’s Bond Buyback Push Puts Kevin Warsh in a Tough Spot — Peter Schiff Says Treasury ‘Pulled the Rug Out From Under’](https://longbridge.com/en/news/296615127.md)
- [Cocoa Prices Fall on Rising Nigerian Cocoa Exports](https://longbridge.com/en/news/296637826.md)
- [FOCUS-Green giant: How Taylor Farms became a top salad supplier before US diarrhea outbreak](https://longbridge.com/en/news/296469939.md)
- [US Cocoa Futures (COCOA-F) Surges on Aug 19: Key Factors to Watch](https://longbridge.com/en/news/296344984.md)
- [JL Mag Rare-Earth seeks shareholder nod to shift USD 15 million of convertible bond proceeds from H-share buybacks to debt repayment, raw materials](https://longbridge.com/en/news/296493279.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**